Alexandria venture investments achieves fifth consecutive annual #1 most active corporate investor in biopharma

Pasadena, calif., jan. 10, 2022 /prnewswire/ -- alexandria venture investments, the strategic venture capital platform of alexandria real estate equities, inc. (nyse: are), an urban office reit and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life science, agtech and technology campuses in aaa innovation cluster locations, today announced that it was recognized by silicon valley bank in its "healthcare investments and exits: annual 2022 report" as the #1 most active corporate investor in biopharma by new deal volume (2020–2021) for the fifth consecutive year.
ARE Ratings Summary
ARE Quant Ranking